Literature DB >> 15185844

Analgesic and anti-inflammatory activities of a fraction rich in oncocalyxone A isolated from Auxemma oncocalyx.

M A D Ferreira1, Osmar D R H Nunes, Juvenia B Fontenele, Otília D L Pessoa, Telma L G Lemos, Glauce S B Viana.   

Abstract

In the present work we studied the antinociceptive and antiedematogenic effects of a quinone fraction (QF) isolated from the heartwood of Auxemma oncocalyx Taub. The major constituent of QF, which represented around 80% of this fraction, was a terpenoid quinone named oncocalyxone A (1). Results show that QF (10 and 30 mg/kg body wt., i.p.) significantly inhibited paw edema induced by carrageenan at the second, third, and fourth hours. The effect was dose-dependent and long lasting, and QF was less effective orally. An antiedematogenic effect was also demonstrated in the dextran-induced paw edema. In this model, however, QF was somewhat less potent. QF (1 and 5 mg/kg body wt., i.p.) inhibited acetic acid-induced abdominal contractions in mice in a dose-dependent manner. In addition, QF (5 and 10 mg/kg body wt., i.p.) inhibited only the second phase (inflammatory) in the formalin test, and showed no effect in the hot-plate test in mice. The antinociceptive activity of QF was predominantly peripheral and independent of the opioid system. The observed effects of QF are, at least in part, probably due to the presence of oncocalyxone A (1).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185844     DOI: 10.1078/0944711041495227

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

Review 1.  Database survey of anti-inflammatory plants in South America: a review.

Authors:  Gedson Rodrigues de Morais Lima; Camila de Albuquerque Montenegro; Cynthia Layse Ferreira de Almeida; Petrônio Filgueiras de Athayde-Filho; José Maria Barbosa-Filho; Leônia Maria Batista
Journal:  Int J Mol Sci       Date:  2011-04-21       Impact factor: 5.923

2.  Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.

Authors:  M A D Ferreira; N R F do Nascimento; C M de Sousa; O D L Pessoa; T L G de Lemos; J S Ventura; M Schattner; A M Chudzinski-Tavassi
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

3.  Antinociceptive and anti-tussive activities of the ethanol extract of the flowers of Meconopsis punicea Maxim.

Authors:  Xiaofei Shang; Dongsheng Wang; Xiaolou Miao; Yu Wang; Jiyu Zhang; Xuezhi Wang; Yu Zhang; Hu Pan
Journal:  BMC Complement Altern Med       Date:  2015-05-22       Impact factor: 3.659

4.  Oncocalyxone A functions as an anti-glycation agent in vitro.

Authors:  Ingrid Sofia Vieira de Melo; Aldenir Feitosa Dos Santos; Telma Leda Gomes de Lemos; Marília Oliveira Fonseca Goulart; Antônio Euzébio Goulart Santana
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Magnetic nanosystem for cancer therapy using oncocalyxone a, an antitomour secondary metabolite isolated from a Brazilian plant.

Authors:  Antônio C H Barreto; Vivian R Santiago; Rafael M Freire; Selma E Mazzetto; Juliano C Denardin; Giuseppe Mele; Igor M Cavalcante; Maria E N P Ribeiro; Nágila M P S Ricardo; Tamara Gonçalves; Luigi Carbone; Telma L G Lemos; Otília D L Pessoa; Pierre B A Fechine
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

Review 6.  MAOS and medicinal chemistry: some important examples from the last years.

Authors:  Nailton M Nascimento-Júnior; Arthur E Kümmerle; Eliezer J Barreiro; Carlos A M Fraga
Journal:  Molecules       Date:  2011-11-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.